CXCL10 and toxic epidermal necrolysis: As IP-10 acts as an inhibitor of neovascularization [48], it has been hypothesized by Yoshikawa et al. [46] that downregulation in IP-10 contributes to the progression of conjunctivalization and neovascularization in Stevens–Johnson syndrome and toxic epidermal necrolysis cases.